Navigation Links
Cases Involving Bard IVC Filter Failure Allegations Now Being Investigated by Resource4thePeople Attorneys
Date:3/28/2013

San Diego, CA (PRWEB) March 28, 2013

http://www.resource4thepeople.com/defectivemedicaldevices/bard-ivc.html

Resource4thePeople announced today that due to an increased number of inquiries from consumers its attorneys are now investigating cases that involve allegations that Bard IVC Filters may have failed and caused serious side effects for patients.

“The fact that a respected medical group has responded* to concerns generated by consumers has increased the number of inquiries we are receiving from patients who may have suffered serious side effects from problems with Bard IVC Filters,” said Resource4thePeople.

“Therefore, we are announcing that our nationwide legal team is now actively investigating these claims and are offering free consultations to consumers who contact us about these allegations.”

Resource4thePeople said the consumer inquiries generated by recent developments that have put the safety of these devices in question include the announcement of a reevaluation from medical professionals and increasing numbers of Adverse Event Reports compiled by the Food and Drug Administration.

The professional review is being launched by The Society of Interventional Radiology and Society for Vascular Surgery,* which said that it will form a task force to measure the health risk of IVC filters to patients.

The Food and Drug Administration also has warned** about increasing numbers of Adverse Event Reports detailing risks involved with the use of the devices.

"The fact that a respected medical society and the FDA are both raising concerns about the safety of IVC filters has generated a great deal of patient concern and questions to us about the availability of legal advice," said Resource4thePeople.

"One of the devices mentioned frequently in the listing of over 900 Adverse Event Reports is the C.R. Bard Filter. In response to these inquiries from consumers we are providing links to lawyers who are offering free consultations."

These consultations are now being offered to provide consumers with a comprehensive review of the legal options that may be available to them to seek compensation for medical costs, pain and suffering and other expenses related to an IVC failure, said Resource4thePeople.

IVC filters -- inferior vena cava filters -- are medical devices that are designed to prevent blood clots in patients at risk for a pulmonary embolism in cases in which an anticoagulant is contraindicated or proven ineffective.

The FDA's warning issued to health care professionals and consumers reports that serious health problems can occur on these spider-like devices when the legs that extend from it to block clots break off.

What can then occur, according to the FDA is that these broken parts from the filter may travel to other parts of the body and cause serious problems such as lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.

Resource4thePeople notes that class-action lawsuits were recently filed by patients who had Bard IVC filters implanted in their bodies and claim to have suffered serious health problems.***

The lawsuits allege that the devices are prone to fracture and cause tears in body organs, including the heart and that C.R. Bard is liable because company officials were aware of IVC filters problems but failed to adequately warn patients and health care professionals.

The lawsuit claims that an estimated 100,000 of the devices have been implanted in patients in the United States.

These lawsuits and the medical society’s formation of an IVC filter follow the warning issued by the FDA detailing the large number of Adverse Event Reports:

"Since 2005, the FDA has received 921 device adverse event reports involving IVC filters, of which 328 involved device migration, 146 involved embolizations (detachment of device components), 70 involved perforation of the IVC, and 56 involved filter fracture. Some of these events led to adverse clinical outcomes in patients. These types of events may be related to a retrievable filter remaining in the body for long periods of time, beyond the time when the risk of pulmonary embolism (PE) has subsided.

"The FDA is concerned that these retrievable IVC filters, intended for short-term placement, are not always removed once a patient’s risk for PE subsides. Known long term risks associated with IVC filters include but are not limited to lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation."

The FDA recommended that health care professionals responsible for the ongoing care of patients with retrievable IVC filters consider removing the filter as soon as protection from pulmonary embolisms is no longer needed.

The agency also said that it is continuing to review the medical research about IVC filter problems and would issue an updated report when more information becomes available.

Consumer4thePeople is also recommending that patients who have had IVC filters implanted in their bodies actively research the FDA's Adverse Event Reports files, which are public records.

Resource4thePeople also is announcing its support for The Society of Interventional Radiology and Society for Vascular Surgery's announcement of the formation of a medical review -- PRESERVE -- to analyze the health risk of IVC filters to patients and is encouraged by the following mission statement issued by the group:

"PRESERVE data will allow a systematic, functional view, representative of all filters placed in the United States, thus, all stakeholders—individuals, health care professionals, insurers and government regulators—will be armed with the knowledge they need on patient risk and, subsequently, quality improvement in filter placement, management and retrieval," said SIR President Marshall E. Hicks, M.D.

Sources:
*http://www.sirweb.org/news/newsPDF/Release_PRESERVE_Final_.pdf
**http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm221707.htm
***First Judicial District of Pennsylvania, In the Court of Common Pleas, Philadelphia County; Case ID120800814

Read the full story at http://www.prweb.com/releases/2013/3/prweb10573055.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. d'Oliveira & Associates Offers “No Win - No Fee Promise” on Topamax Cases
2. AvePoint Showcases Enterprise Collaboration Solutions as Title Sponsor of SharePoint Fest Denver 2013
3. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
4. Amirsys Showcases Radiology Products at European Congress of Radiology
5. AvePoint Showcases Compliance Solutions as Gold Sponsor of the IAPP Global Privacy Summit in Washington, DC
6. Tylenol Liver Failure Allegation Lawsuits Update: Resource4thePeople Reports Hearing to Consolidate Federal Cases Is Scheduled
7. Glidewell Laboratories Discontinues Digital Treatment Planning and Guided Surgery Services for Implant Cases
8. Women’s Excellence in Endometriosis Now Open in Lake Orion, Michigan – Dr. Jonathan Zaidan MD Opens Private Center to Treat the Most Complicated Cases of Endometriosis
9. 16 Cases of Kidney Damage in 6 States From Synthetic Pot: CDC
10. In some dystonia cases, deep brain therapy benefits may linger after device turned off
11. MessageSolution Showcases IBM SmartCloud Integration and Award Winning Archiving Solutions at IBM Connect 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill the ... amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates ... be set up in a matter of minutes, or even seconds. The SAFETY STRAP ...
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... said an inventor from Winchester, Va. "I thought that if the nebulizer had a ... treatments rather than fearing them." , He developed the patent-pending NEBY to avoid the ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking ... registration today for its 33rd Annual Issues & Research Conference, March 2-3, ... theme of the conference is “Persistent Challenges and New Opportunities: Using Research to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) ... , the ultimate weight loss and wellness program, at their world headquarters of Omni ... provide immediate and long-term results to anyone seeking weight loss, personal development, a healthy ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... FRISCO, Texas , Dec. 8, 2016 /PRNewswire/ ... new program that brings leading-edge laboratory services and ... the United States , allowing more doctors ... and health care management solutions. Logo ... Hospital systems, under pressure to ...
(Date:12/8/2016)... , December 8, 2016 Information products ... metrics in Scopus , the world,s largest abstract ... access to comprehensive metrics for journals from over 5,000 publishers. The ... which journals to subscribe to and when to adjust a journal,s ... , , ...
Breaking Medicine Technology: